A novel diagnostic score for diagnosing arginine vasopressin deficiency (central diabetes insipidus) or primary polydipsia with basal laboratory and clinical parameters: results from two international multicentre prospective diagnostic studies

What Was Tested

This randomized controlled trial paper looks at Vasopressin.

Therefore, this study aimed to evaluate the diagnostic potential of basal laboratory parameters and to develop a practical diagnostic score.

Data from two international multicentre studies of patients with arginine vasopressin deficiency and primary polydipsia undergoing the hypertonic saline test were used to evaluate the diagnostic potential of basal laboratory tests and to develop a score incorporating laboratory results, symptoms, and medical history.

Why It Was Studied

Distinguishing arginine vasopressin deficiency (central diabetes insipidus) from primary polydipsia is challenging.

There is no validated initial laboratory assessment or diagnostic score to rule-in or rule-out arginine vasopressin deficiency during the first consultation.

Who Took Part

PubMed indexes the participants as young adults, adults, middle-aged adults and older adults, both men and women.

Each cutoff was derived from the first study (development), and their performance was determined in the second study (validation).

How the Study Was Run

In design terms this was a randomized, crossover and multicenter study.

Random assignment meant chance, not the researchers, decided who got Vasopressin and who got the comparison, which limits bias.

Each person switched between Vasopressin and the comparison at some point, usually with a gap in between.

Running at several centres spread the Vasopressin study over different clinics and patient groups.

Data were derived from the initial consultation and a basal laboratory test.

The diagnostic performance in predicting arginine vasopressin deficiency was examined by the receiver operating characteristic (ROC) area under the curve (AUC) and by sensitivity and specificity.

The studies were registered with ClinicalTrials.gov (NCT01940614 and NCT03572166).

What Was Measured

Distinguishing arginine vasopressin deficiency (central diabetes insipidus) from primary polydipsia is challenging.

There is no validated initial laboratory assessment or diagnostic score to rule-in or rule-out arginine vasopressin deficiency during the first consultation.

Topics PubMed links to this paper include Arginine Vasopressin, Diabetes Insipidus, Neurogenic, Polydipsia, Diagnosis, Differential, Polyuria, Osmolar Concentration and Glycopeptides.

What This Means in Plain Language

The paper is a randomized, crossover and multicenter study of Vasopressin.

Results are reported in around 10 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2025 (The lancet. Diabetes & endocrinology), a journal based in England.

More context: the Vasopressin compound page, all human trials.